Cureus August 14, 2022
Barat S. Venkataramany, Jeffrey M. Sutton

Abstract

The COVID-19 pandemic has proven to be a challenge for public health professionals, researchers, clinicians, and patients. One group that has experienced significant difficulties during this time is cancer patients. Data regarding this vulnerable population is scarce, despite novel information about vaccine efficacy, therapeutics, mutations, and comorbidities. In this article, we discuss the need for a greater study of social determinants of health (SDOH) for cancer patients in the context of the COVID-19 pandemic. The effects of SDOH on population health are generally well-understood, but their effects on cancer patients are poorly understood. We further pose questions that may be starting points for the investigation of SDOH in cancer patients during this time. Using SDOH as a tool...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Equity/SDOH, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
The IPPS Proposed Rule Demonstrates the Importance of SDoH
Systemic racism, politics prevent Black expectant mothers from getting needed healthcare
14,280 Black patients moved up transplant waitlist after race scrubbed from criteria
Patient concerns in healthcare digitalisation: Rising inequalities
CMS IPPS Proposed Rule: Expansion of SDoH Designations as CCs

Share This Article